Accelerated hyperfractionation in patients with non-small cell bronchogenic cancers as a cost-effective and user- and patient-friendly schedule

Cancer Investigation

Volumn 18, Issue 6, 2000, Pages 537-543

  Herskovic, A ^a,d   Fisher, Jackie ^b   Orton, Barbara ^b   Lee, Choon K ^b   Chang, Jung H ^b   Sandhu, Taljit ^b   Prysby, Debby ^b   Scott, Charles ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b OAKWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^c AMERICAN COLLEGE OF RADIOLOGY   (United States)

^d NORTHWEST COMMUNITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION FIELD; TREATMENT OUTCOME;

EID: 0033915579     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357900009012193     Document Type: Article

References (17)

1. Sause WT, Pajak T, Emami B, et al: The Radiation Therapy Oncology Group experience altered fractionation in lung cancer. Lung Cancer 9:229-238, 1993.
2. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) and Eastern Cooperative Oncology Group (ECOG)-4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87:198-205, 1995.
3. Saunders MI, Dische S, Grosch EJ, et al: Experience with Chart, Int J Radiat Oncol Biol Phys 21:871-878, 1991.
4. Saunders MI, Dische S, Barrett A, et al: Randomized multicentre trials of CHART vs. Conventional radiotherapy in head and neck and non-small cell lung cancer: an interim report. Br J Cancer 72: 1455-1462, 1966.
5. Saunders M, Dische S, Barrett A. et al: Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: a randomized multicentre trial. Lancet 350:161-165, 1947.
6. Saunders MI, Rojas A, Lyn BE, et al: Experience with dose escalation using CHARTWELL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small cell lung cancer. Br J Cancer 78:1323-1328, 1998.
7. Herskovic A, Scott C, Demas W, et al: Accelerated hyperfractionation for bronchogenic cancer - Radiation Therapy Oncology Group 9205. Am J Clin Oncol (in press).
8. Herksovic A, Orton C, Seyedsadr M, et al: Initial experience with a practical hyperfractionated accelerated radiotherapy regimen. Im J Radiat Oncol Biol Phys 21:1275-1281, 1992.
9. Mehta M, Tannehill S, Adak S, et al: Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small cell lung cancer: results of Eastern Cooperative Oncology Group 4593. J Clin Oncol 16:3518-3523, 1998.
10. Ali M, Kraut A, Valdivieso MJ, et al: Phase II study of weekly alternating combination chemotherapy with concurrent hyperfractionated radiotherapy in limited stage small cell lung cancer. Cancer (in press).
11. Fu X-L, Jiang G-L, Wang L-J, et al: Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial. Int J Radiat Oncol Biol Phys 39:545-552, 1997.
12. King SC, Acker JC, Kussin PS, et al: High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of non-small cell lung cancer: unusual toxicity and promising early results. Int J Radiat Oncol Biol Phys 36:593-599, 1996.
13. Emami B, Perez CA, Herskovic A, et al: Phase I/II study of treatment of locally advanced (T3T4) nun-oat cell lung cancer with high dose radiotherapy (rapid fractionation): Radiation Therapy Oncology Group study. Int J Radiat Oncol Biol Phys 15:1021-1025, 1988.
14. Graham MV, Pajak TE, Herskovic AM, et al: Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): long term results. Int J Radiat Oncol Biol Phys 31:819-825, 1995.
15. Byhardt RW, Pajak TE, Emami B, et al: A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous adeno - and large cell carcinoma of the lung: report of Radiation Therapy Oncology group 84-07. Int J Radiat Oncol Biol Phys 26:459-468, 1992.
16. Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 58: 515-528, 1985.
17. Dale RG. The application of the linear-quadratic model to fractionaled radiotherapy when there is incomplete normal tissue recovery between fractions and possible implications for treatments involving multiple fractions per day. Br J Radiol 59:919-927, 1986.